Today's Veterinary Practice

TVP_JUL-AUG2018

Today's Veterinary Practice provides comprehensive information to keep every small animal practitioner up to date on companion animal medicine and surgery as well as practice building and management.

Issue link: https://todaysveterinarypractice.epubxp.com/i/997103

Contents of this Issue

Navigation

Page 27 of 87

What do dog owners think? only 62% of dog owners remembered their veterinarian's exact flea & tick recommendation 2 1 Brakke Consulting US Flea Control & Heartworm Markets report; 2015. 2 Lavan et al. Parasites & Vectors. 2017;10:284. 3 Lavan et al. J Vet Sci Technol. 2017;8:439. 4 BRAVECTO Chew for Dogs [prescribing information]. Madison, NJ: Merck Animal Health; 2014. 5 BRAVECTO Topical Solution for Dogs [prescribing information]. Madison, NJ: Merck Animal Health; 2016. 6 BRAVECTO Topical Solution for Cats [prescribing information]. Madison, NJ: Merck Animal Health; 2016. 7 Rohdich et al. Parasites & Vectors. 2014;7:83. 8 Freedom of Information Summary, NADA 141-426. Approved May 15, 2014. *BRAVECTOkillsfleasandpreventsfleainfestationsfor12weeks.BRAVECTO Chew and BRAVECTO Topical Solution for Dogs kill ticks (black-legged tick, American dog tick, and brown dog tick) for 12 weeks and also kill lone star ticks for 8 weeks. BRAVECTO Topical Solution for Cats kills ticks (black-legged tick) for 12 weeks and American dog ticks for 8 weeks. IMPORTANT SAFETY INFORMATION:BRAVECTOhasnotbeenshowntobeeffectivefor12-weeks'durationinpuppiesorkittenslessthan6monthsofage.BRAVECTO Chew: The most common adverse reactions recorded in clinical trials were vomiting, decreased appetite, diarrhea, lethargy, polydipsia,andflatulence.BRAVECTOisnoteffectiveagainstlonestarticksbeyond8weeksofdosing.BRAVECTO Topical Solution for Dogs: The most common adverse reactions recorded in clinical trials were vomiting, hair loss, diarrhea, lethargy, decreased appetite, and moist dermatitis/ rash.BRAVECTOisnoteffectiveagainstlonestarticksbeyond8weeksofdosing.Fortopicaluseonly.Avoidoralingestion.Usecautionindogswithahistoryofseizures.Seizureshavebeenreportedindogsreceivingfluralaner,evenindogswithoutahistoryofseizures.BRAVECTO Topical Solution for Cats:Themostcommonadversereactionsrecordedinclinicaltrialswerevomiting,itching,diarrhea,hairloss,decreasedappetite,lethargy,andscabs/ulceratedlesions.BRAVECTOisnoteffectiveagainstAmericandogticksbeyond8weeksofdosing.Fortopicaluseonly.Avoidoralingestion.The safety of BRAVECTO has not been established in breeding, pregnant and lactating cats. Use with caution in cats with a history of neurologic abnormalities. Neurologic abnormalities have been reported in cats receiving BRAVECTO, even in cats without a history of neurologic abnormalities. Copyright © 2018 Intervet Inc., d/b/a Merck Animal Health, a subsidiary of Merck & Co. Inc. All rights reserved. US/BRV/0118/0012a The average dog owner doses their pet with approximately 4.6 monthly flea treatments in a year. 1 Do pet owners follow the 12-month recommendation? No. Veterinarians recommend year-round flea and tick protection but... The challenge of dog owners agree that their pets should have 12 months of flea and tick protection 2 73% while As much as people love their pets, it can be hard to remember to give flea & tick treatment every month. BRAVECTO can help.

Articles in this issue

Archives of this issue

view archives of Today's Veterinary Practice - TVP_JUL-AUG2018